Cambridge Investment Research Advisors, Inc. Trans Medics Group, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 7,049 shares of TMDX stock, worth $495,756. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,049
Previous 2,604
170.7%
Holding current value
$495,756
Previous $409,000
7.58%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TMDX
# of Institutions
346Shares Held
30.6MCall Options Held
671KPut Options Held
858K-
Vanguard Group Inc Valley Forge, PA3.64MShares$256 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$186 Million0.01% of portfolio
-
State Street Corp Boston, MA1.36MShares$95.7 Million0.0% of portfolio
-
Fil LTD Hamilton, D01MShares$70.4 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3993KShares$69.8 Million0.07% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.24B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...